ÃØÃÜÑо¿Ëù

Internal Server Error
Unlock full details of this profile with our freeÌýLiteÌý±è±ô²¹²Ô!
Signup and get free access

Last updated:

About Longevity Vision Fund

Longevity Vision Fund is a venture capital firm founded in 2018. It is primarily based out of New York City, United States. As of Aug 2022, Longevity Vision Fund has invested in 17 companies. It primarily invests in Series B round in United States based startups. Its investments are spread across a wide range of sectors from Life Sciences to High Tech and HealthTech. Most recently it led the $300M Series C round of Tessera Therapeutics along with Flagship Pioneering. This round also saw participation from T. Rowe Price and other investors.
Overall, Longevity Vision Fund portfolio has seen 2 unicorns, 1 IPO and 2 acquisitions including key companies like 4D Molecular Therapeutics, Freenome and Insilico. A lot of funds co-invest with Longevity Vision Fund, with names like Bold Capital Partners sharing a substantial percentage of its portfolio.
Longevity Vision Fund has team of 10 people including 3 partners.
Key Metrics
Team Members
, &
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series B, Series A &
Portfolio IPOs
Portfolio Acquisitions
Portfolio Unicorns
Portfolio Soonicorns
Get Longevity Vision Fund's portfolio delivered to your inbox!

Longevity Vision Fund's Investments by Stage

Longevity Vision Fund has made 5 investments in Series B stage with an average round size of $70.1M, 2 investments in Series A stage with an average round size of $4M and 2 investments in Series C stage with an average round size of $188M.
Here are Longevity Vision Fund's investments by stage:
Note: We have considered here, only first round of investments
Breakdown of Longevity Vision Fund's investments by stage of entrySeries B (5)Series A (2)
Stage of entry
No. of Investments
Series B
5
Series A
2
Series C
2

Longevity Vision Fund's Investments by Sector

Longevity Vision Fund has a diverse portfolio, with companies operating in the Life Sciences, High Tech, HealthTech, Artificial Intelligence - Industry Applications and Enterprise Applications. Notably, it has invested in 12 Enterprise (B2B) companies, 12 Tech companies, 6 Artificial intelligence companies and at least 5 companies focusing on Software.
Here are Longevity Vision Fund's investments by sector:
Note: We have considered here, only first round of investments
Breakdown of Longevity Vision Fund's investments by sectorsLife Sciences (7)High Tech (5)
Sector
No. of Investments
Life Sciences
7
High Tech
5
HealthTech
4
Artificial Intelligence - Industry Applications
3
Enterprise Applications
3
Others
2

Longevity Vision Fund's Investments by Geography

Longevity Vision Fund has made most investments in United States (8), followed by China where it has made 1 investment.
Here are Longevity Vision Fund's investments by geography:
Note: We have considered here, only first round of investments
Breakdown of Longevity Vision Fund's investments by countriesUnited States (8)China (1)
Country
No. of Investments
United States
8
China
1

Longevity Vision Fund's recent investments

Longevity Vision Fund has not made any investment in 2025 so far.
Here are the most recent investments by Longevity Vision Fund:
Date
Company
Location
Round Details
Round Amount
Co-Investors
Aug 16, 2022
United States
Series C
$123M
[+5]
Apr 19, 2022
United States
Series C
$300M
ADIA [+8]
Nov 02, 2021
United States
Series B
$100M
Jun 10, 2021
United States
Series B
$98M
TMCP [+3]
Aug 20, 2020
United States
Series B
$40M
lockGet the detailed list of all investments by Longevity Vision Fund. Download now!

Unicorns in Longevity Vision Fund's Portfolio

Longevity Vision Fund has 2 unicorns in its portfolio - Insilico and Freenome.ÌýThe most recent unicorn in their portfolio is Insilico. It became a unicorn in 2025, 5 years after Longevity Vision Fund first invested in it.
Here is a list of unicorns in Longevity Vision Fund's portfolio:
ÃØÃÜÑо¿Ëù Score
Company
Short Description
Founded year
Sector
Location
Company Stage
First Investment/ Acquisition Details
64
AI-enabled bioinformatics platform for drug discovery and biomarker development
2014
Hong Kong
Series E
uvvdfdy
72
Provider of a deep learning platform for detecting circulating cancer-related markers
2014
San Francisco
Series E
ruktrqp

IPOs and Publicly Listed companies in Longevity Vision Fund's Portfolio

1 of Longevity Vision Fund's portfolio company became public - Ìý4D Molecular Therapeutics.ÌýIt got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ), in Dec 2020 at marketcap of $580M
Here are Longevity Vision Fund's portfolio companies that went public:
Company
IPO Date
First Invested on
First Round of Investment
Round Size
Dec 11, 2020
Jun 16, 2020
Series C
$75M

Acquired companies in Longevity Vision Fund's Portfolio

2 companies from Longevity Vision Fund's portfolio have been acquired.ÌýThe most recent acquisition were Sigilon in Jun 2023Ìýby Lilly for $34.6M.
Here are Longevity Vision Fund's portfolio companies that got acquired most recently:
Company
Acquisition Date
First Invested on
First Round of Investment
Round Size
Jun 30, 2023
Mar 17, 2020
Series B
$80.3M
Sep 02, 2020
Jul 14, 2020
Series A
Undisclosed

Team profile of Longevity Vision Fund

Longevity Vision Fund has a team of 10 membersÌýincluding 3 PartnersÌýlocated in United States, United Kingdom and . Longevity Vision Fund's team does not sit on the board of any company as of now.
Here is a list of all team members in Longevity Vision Fund:
Name
Designation
Location
Board Memberships
Contact details
Partner
London
-
Partner
London
-
Partner
New York City
-
Advisor
United States
-
Advisor
Copenhagen
-
-
Advisor
Birmingham
-
-
Associate
Zurich
-
Analyst
Boston
-
Analyst
New York
-
lockGet the full list of Longevity Vision Fund's team & partners for free. Download now!

Co-investors of Longevity Vision Fund

Over the past 6 years, 122 investors have co-invested in Longevity Vision Fund's portfolio companies.

  • Invested before Longevity Vision Fund:ÌýJuvenescence, Pfizer Venture Investments and 35 others have invested in rounds before Longevity Vision Fund. There are 2 companies where Juvenescence has invested before Longevity Vision Fund and 1 company where Pfizer Venture Investments has invested before Longevity Vision Fund.
  • Top Co-investors of Longevity Vision Fund:Ìý53 investors entered a company along with Longevity Vision Fund. These include investors like Bold Capital Partners (2 companies).
  • Invested after Longevity Vision Fund:ÌýA total of 32 investors have invested in Longevity Vision Fund's portfolio after their investments. Top Investors include TDK Ventures (1 company), Solasta Ventures (1 company) and Action Potential Venture Capital (1 company).
Get full list of Longevity Vision Fund's co-investors delivered to your inbox!

Recent News related to Longevity Vision Fund

•
BioPharmaDive•Aug 16, 2022•Senda Biosciences, Flagship Pioneering, Qatar Investment Authority, and 4 others
•
PEdaily•Apr 28, 2022•Tessera Therapeutics, ADIA, Alaska Permanent Fund, Altitude Life Science Ventures and 7 others
•
Global Legal Chronicle•Apr 22, 2022•Tessera Therapeutics, ADIA, Alaska Permanent Fund, Altitude Life Science Ventures and 17 others
•
Global AgInvesting•Nov 03, 2021•, RiverVest Venture Partners, , and 9 others
•
Fierce Biotech•Nov 02, 2021•, RiverVest Venture Partners, , and 16 others
•
FinSMEs•Jun 12, 2021•Senda Biosciences, Magnum Partners, Longevity Vision Fund, TMCP and 5 others
•
Medical Product Outsourcing•Oct 08, 2020•Exo, Remagine Ventures, Action Potential Venture Capital, TDK Ventures and 10 others
•
ACN Newswire•Sep 02, 2020•Deep Longevity, Human Longevity, Emerging Technology Partners, Bold Capital Partners and 1 other
•
MassDevice•Aug 24, 2020•Remagine Ventures, Exo, Action Potential Venture Capital, Intel Capital and 10 others
•
VCJ•Jul 14, 2020•Deep Longevity, Human Longevity, , Bold Capital Partners and 2 others
Our Lite Plan Awaits you - Its Free!
Sign up now to unlock full access to curated data
  • check icon 4M+ Companies
  • check icon 212K+ Investors
  • check icon 580K+ Funding Rounds
  • check icon 207K+ Acquisitions
  • check icon 2.9K+ Sectors
  • check icon 57K+ Business Models

Accel PartnersPartechIN-Q-TEL - USPalo Alto NetworkMaersk GrowthFujitsuTenityStanford
Unlock full details of this profile with our freeÌýLiteÌý±è±ô²¹²Ô!Signup and get free accessÌýarrow-right-long